| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/28/1998 | CA2272865A1 Alkyl peptide amides and applications |
| 05/28/1998 | CA2272824A1 Insulin-like growth factor 1 receptor (igf-1r) antisense oligonucleotide-treated breast cancer cells composition |
| 05/28/1998 | CA2272747A1 Hybrid compositions for intracellular targeting |
| 05/28/1998 | CA2272578A1 Post-mitotic neurons containing adenovirus vectors that modulate apoptosis and growth |
| 05/28/1998 | CA2272545A1 Nucleotide and protein sequences of liver activin/inhibin and methods based thereon |
| 05/28/1998 | CA2272280A1 A method and composition for enabling passage through the blood-brain barrier |
| 05/28/1998 | CA2272095A1 Peptidomimetics containing 6-peptidylamino-1-naphthalenesulfonamide moieties |
| 05/28/1998 | CA2272093A1 Method for treating neoplasia using humanized antibodies which bind to antigen a33 |
| 05/28/1998 | CA2272073A1 Local use of il-1ra in corneal transplant rejection or disorders of the eye |
| 05/28/1998 | CA2272050A1 Secreted proteins and polynucleotides encoding them |
| 05/28/1998 | CA2271954A1 Identification of bap-1, a protein that binds to integrin and is involved in integrin-mediated signal transduction |
| 05/28/1998 | CA2271935A1 Modulation of interactions between myosin and integrins |
| 05/28/1998 | CA2271783A1 Survivin, a protein that inhibits cellular apoptosis, and its modulation |
| 05/28/1998 | CA2271769A1 Use of conotoxin peptides imi and mii as cardiovascular agents |
| 05/28/1998 | CA2271714A1 Preprotachykinin-c gene encoding substance z tachykinin precursor |
| 05/28/1998 | CA2271681A1 Novel semaphorin genes (i) |
| 05/28/1998 | CA2271288A1 Antiviral peptide derivatives |
| 05/28/1998 | CA2270903A1 Biosynthetic gene murg from streptococcus pneumoniae |
| 05/28/1998 | CA2270876A1 N-(aryl/heteroaryl) amino acid derivatives, pharmaceutical compositions comprising same, and methods for inhibiting .beta.-amyloid peptide release and/or its synthesis by use of such compounds |
| 05/28/1998 | CA2270407A1 Human kdel receptor |
| 05/28/1998 | CA2270203A1 Agent for the metabolic treatment of multiple sclerosis |
| 05/28/1998 | CA2267634A1 Methods and compounds for inhibiting .beta.-amyloid peptide release and/or synthesis |
| 05/28/1998 | CA2266659A1 Pretreatment with growth factors to protect against cns damage |
| 05/28/1998 | CA2243161A1 Use of interferon-beta to treat retinal edema |
| 05/28/1998 | CA2217168A1 A polypeptide, and a dna sequence to which a protein containing the polypeptide binds |
| 05/27/1998 | EP0844307A1 Candida albicans protein caYAE1 |
| 05/27/1998 | EP0844305A2 hRAD54 |
| 05/27/1998 | EP0844254A2 Method for producing antithrombin-III, method for purifying it, and preparation containing it |
| 05/27/1998 | EP0844253A1 Polynucleotides and polypeptides related to the "Tubby" family |
| 05/27/1998 | EP0844003A1 Remedy for coxsackie virus b infection |
| 05/27/1998 | EP0843732A1 Natural or synthetic retroelement sequence enabling nucleotide sequence insertion into a eukaryotic cell |
| 05/27/1998 | EP0843726A1 Opioid antagonists and methods of their use |
| 05/27/1998 | EP0843674A1 Lubeluzole n-oxide |
| 05/27/1998 | EP0843583A1 Golf club receptacle |
| 05/27/1998 | EP0843557A1 Methods for detecting, identifying, isolating, and selectively labelling and targeting th1 lymphocytes by means of the lag-3 protein |
| 05/27/1998 | EP0843516A1 Peptides and pharmaceutical compositions thereof for treatment of disorders or diseases associated with abnormal protein folding into amyloid or amyloid-like deposits |
| 05/27/1998 | EP0711303A4 Biotinylation of proteins |
| 05/27/1998 | EP0658082B1 Combination of germicidal agents |
| 05/27/1998 | EP0587571B1 HUMAN GALANIN, cDNA CLONES ENCODING HUMAN GALANIN AND A METHOD OF PRODUCING HUMAN GALANIN |
| 05/27/1998 | CN1183120A Low oxygen affinity mutant hemoglobin |
| 05/27/1998 | CN1183117A Intracelluar domain of the HER-2/neu protein for prevention or treatment of malignancies |
| 05/27/1998 | CN1183104A Cyclic pentapeptide LH-RH receptor antagonists |
| 05/27/1998 | CN1183103A Peptide compositions with growth factor-like activity |
| 05/27/1998 | CN1183102A Heterocyclecarbonyl amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 05/27/1998 | CN1182793A Human tumor necrotic factor mutant |
| 05/27/1998 | CN1182746A Novel heterocycles as inhibitors of leucocyte adhesion and as VLA-4 antagonists |
| 05/27/1998 | CN1038512C Productive method of medicine for improving growth of liver cell |
| 05/27/1998 | CA2217153A1 Human methionine synthase: cloning, and methods for evaluating risk of neural tube defects, cardiovascular disease, and cancer |
| 05/27/1998 | CA2216625A1 Novel compounds |
| 05/26/1998 | US5756832 Process for preparing amino acid esters useful as intermediates for compounds containing a fused bicyclic ring |
| 05/26/1998 | US5756761 Preparing hot saturated aqueous solutions of at least two different amino acids, one polar hydrophilic and another nonpolar hydrophobic, mixing, drying |
| 05/26/1998 | US5756710 Inhibit human immunodeficiency virus activity |
| 05/26/1998 | US5756700 Nucleic acid encoding human signal transducer and activator of transcription 4 |
| 05/26/1998 | US5756699 Immunotoxins comprising ribosome-inactivating proteins |
| 05/26/1998 | US5756687 Isolation of components of interest from milk |
| 05/26/1998 | US5756684 Anticancer agents; viricides |
| 05/26/1998 | US5756681 Introducing into the reproductive tract of human at effective contraceptive amount of beta-lactoglobulin either alone or in combination of excipient, carrier or diluent to prevent the pregnancy |
| 05/26/1998 | US5756676 Mammalian protein associated with uncontrolled cell division |
| 05/26/1998 | US5756675 IL-1α derivatives |
| 05/26/1998 | US5756674 Fusion proteins |
| 05/26/1998 | US5756673 Regulation of smooth muscle cell proliferation |
| 05/26/1998 | US5756672 Refolding of polypeptides |
| 05/26/1998 | US5756671 Activation cells growth, differentiation |
| 05/26/1998 | US5756669 Mutants |
| 05/26/1998 | US5756668 Hypermethylated in cancer polypeptide, HIC-1 |
| 05/26/1998 | US5756666 Peptides capable of inducing immune response to HIV |
| 05/26/1998 | US5756665 Signal peptide which initiates expression of a bactericide composition |
| 05/26/1998 | US5756664 Genetic engineering of proteins with nucleotide sequences for bones |
| 05/26/1998 | US5756663 Mediates hypotonic cell swelling induced calcium increase in cells |
| 05/26/1998 | US5756662 Detecting trypanosoma infection by contacting biological sample with specified polypeptide, detecting presence of antibodies binding thereto |
| 05/26/1998 | US5756534 Retroviral protease inhibitors |
| 05/26/1998 | US5756533 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 05/26/1998 | US5756513 Adjustment of the prolactin cycle |
| 05/26/1998 | US5756494 Protein kinase inhibitors for treatment of neurological disorders |
| 05/26/1998 | US5756486 Cyclized nucleotide; viricide |
| 05/26/1998 | US5756482 Method of attenuation of nervous system damage |
| 05/26/1998 | US5756481 Cysteine |
| 05/26/1998 | US5756476 Inhibition of cell proliferation using antisense oligonucleotides |
| 05/26/1998 | US5756468 Lyophilized solid drug consists of a compound having botulinum toxicity, stabilizing protein, polysaccharide sugar and thioalkyl compound selected from methionine and cysteine; storage stability |
| 05/26/1998 | US5756467 Useful in prevention and therapy of obesity and cardiovascular diseases in humans and animals; administering in food and feeds |
| 05/26/1998 | US5756466 Inhibitors of interleukin-1β converting enzyme |
| 05/26/1998 | US5756465 Protease enzyme inhibitors |
| 05/26/1998 | US5756464 Therapeutic uses of BPI protein products in humans with hemmorhage due to trauma |
| 05/26/1998 | US5756463 Use of insulin and IGF-1 |
| 05/26/1998 | US5756462 Polypeptide isolated from venom of spider |
| 05/26/1998 | US5756461 Antidiabetic agents using leptin proteins |
| 05/26/1998 | US5756460 Administering to modulate insulin secretion in humans |
| 05/26/1998 | US5756459 Insecticidally effective peptides isolatable from phidippus spider venom |
| 05/26/1998 | US5756458 Stabilized potent GRF analogs |
| 05/26/1998 | US5756457 Neural regeneration using human bone morphogenetic proteins |
| 05/26/1998 | US5756456 Methods involving sensory and motor neuron derived factor (SMDF) |
| 05/26/1998 | US5756455 Amplification of human MDM2 gene in human tumors |
| 05/26/1998 | US5756454 Collagen-induced platelet aggregation inhibitor |
| 05/26/1998 | US5756453 Use of angiogenic lipids for vascularizing tissue |
| 05/26/1998 | US5756452 Cyclic polypeptide |
| 05/26/1998 | US5756451 Antiischemic agents |
| 05/26/1998 | US5756450 Water soluble monoesters as solubilisers for pharmacologically active compounds and pharmaceutical excipients and novel cyclosporin galenic forms |
| 05/26/1998 | US5756449 Intranasal, oral, buccal, parenteal, topical, or rectal administeration or direct inhalation; atleast 4 amino acid residues or salts and atleast one of the amino acids is substituted n-alkyl amino acid |
| 05/26/1998 | US5756448 Constitute activator of retinoid (CAR) receptor polypeptides |
| 05/26/1998 | US5756349 Culture of cells and radioimmunoassay |